Clinical Trial Update: Amifostine for Head and Neck Irradiation in Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating amifostine to protect normal tissues during head and neck irradiation in patients with lymphoma. The study includes Hodgkin lymp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Amifostine (amifostine)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Lymphoma, Hodgkin's Disease | Phase 2 | Status: COMPLETED